NAMPT and cancer: Visfatin has turned out to be overexpressed in various cancers, such as the gastroesophageal, colorectal, prostatic, pancreas, and postmenopausal breast cancer [132,133,134], and has been implicated in cancer proliferation, metastasis, cell angiogenesis, and drug resistance [132].